Wilker E, Lu J, Rho O, Carbajal S, Beltrn L, DiGiovanni J
Comment: One commenter pointed to the significant methodological changes to individual measures finalized in the Fiscal Year (FY) 2026 Inpatient Prospective Payment System (IPPS) final rule (90 FR 36997 through 37027), such as the use of Medicare Advantage (MA) data, changes in risk adjustment models, removal of COVID-19 vaccination measures, and re-baselining of HAI measures, and urged CMS to delay implementation of Stage 2 for a year after updated data is publicly available and after conducting a comprehensive analysis of the combined effects before finalizing further penalties
Missed Dose : If a dose is missed within 5 days , inject it as soon as possible
If further glycemic control is needed, the dose may be increased to a maximum of 1.8 mg daily
In many cases, what happens is: finish your current cycle of tirzepatide (or reduce to a stable dose), then after a defined interval (often one week or so) begin retatrutide at the low dose under provider monitoring